BlackRock’s HUTCHMED HCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.8K | Sell |
791
-38,888
| -98% | -$569K | ﹤0.01% | 5382 |
|
|
2025
Q4 | $529K | Buy |
39,679
+16,459
| +71% | +$240K | ﹤0.01% | 4469 |
|
|
2025
Q3 | $366K | Buy |
23,220
+4,253
| +22% | +$70K | ﹤0.01% | 4539 |
|
|
2025
Q2 | $285K | Sell |
18,967
-54,341
| -74% | -$794K | ﹤0.01% | 4584 |
|
|
2025
Q1 | $1.1M | Buy |
73,308
+57,707
| +370% | +$853K | ﹤0.01% | 4165 |
|
|
2024
Q4 | $225K | Sell |
15,601
-2,540
| -14% | -$45.4K | ﹤0.01% | 4599 |
|
|
2024
Q3 | $354K | Buy |
18,141
+457
| +3% | +$8.26K | ﹤0.01% | 4408 |
|
|
2024
Q2 | $303K | Buy |
17,684
+335
| +2% | +$6.18K | ﹤0.01% | 4460 |
|
|
2024
Q1 | $291K | Sell |
17,349
-6,175
| -26% | -$93.7K | ﹤0.01% | 4512 |
|
|
2023
Q4 | $426K | Sell |
23,524
-13,860
| -37% | -$252K | ﹤0.01% | 4459 |
|
|
2023
Q3 | $633K | Sell |
37,384
-61,754
| -62% | -$885K | ﹤0.01% | 4355 |
|
|
2023
Q2 | $1.19M | Sell |
99,138
-83,411
| -46% | -$1.14M | ﹤0.01% | 4242 |
|
|
2023
Q1 | $2.38M | Buy |
182,549
+32,160
| +21% | +$527K | ﹤0.01% | 3970 |
|
|
2022
Q4 | $2.22M | Sell |
150,389
-3,601,394
| -96% | -$39.4M | ﹤0.01% | 4097 |
|
|
2022
Q3 | $33.2M | Sell |
3,751,783
-70,584
| -2% | -$888K | ﹤0.01% | 2734 |
|
|
2022
Q2 | $48.3M | Buy |
3,822,367
+305,782
| +9% | +$3.89M | ﹤0.01% | 2522 |
|
|
2022
Q1 | $66.5M | Buy |
3,516,585
+123,396
| +4% | +$3.14M | ﹤0.01% | 2402 |
|
|
2021
Q4 | $119M | Sell |
3,393,189
-69,586
| -2% | -$2.26M | ﹤0.01% | 2091 |
|
|
2021
Q3 | $127M | Buy |
3,462,775
+448,350
| +15% | +$17.6M | ﹤0.01% | 2065 |
|
|
2021
Q2 | $118M | Sell |
3,014,425
-603,523
| -17% | -$17.4M | ﹤0.01% | 2154 |
|
|
2021
Q1 | $102M | Buy |
3,617,948
+87,980
| +2% | +$2.81M | ﹤0.01% | 2186 |
|
|
2020
Q4 | $113M | Buy |
3,529,968
+136,387
| +4% | +$4.19M | ﹤0.01% | 2014 |
|
|
2020
Q3 | $110M | Sell |
3,393,581
-121,985
| -3% | -$3.8M | ﹤0.01% | 1819 |
|
|
2020
Q2 | $97M | Buy |
3,515,566
+362,482
| +11% | +$7.86M | ﹤0.01% | 1858 |
|
|
2020
Q1 | $56.3M | Buy |
3,153,084
+57,980
| +2% | +$1.4M | ﹤0.01% | 1980 |
|
|
2019
Q4 | $77.6M | Sell |
3,095,104
-370,595
| -11% | -$8.11M | ﹤0.01% | 2095 |
|
|
2019
Q3 | $61.8M | Buy |
3,465,699
+175,020
| +5% | +$3.64M | ﹤0.01% | 2166 |
|
|
2019
Q2 | $72.4M | Sell |
3,290,679
-130,969
| -4% | -$3.74M | ﹤0.01% | 2112 |
|
|
2019
Q1 | $105M | Buy |
3,421,648
+279,166
| +9% | +$6.96M | ﹤0.01% | 1845 |
|
|
2018
Q4 | $72.6M | Buy |
+3,142,482
| New | +$97.7M | ﹤0.01% | 2017 |
|
Other funds holding HCM
AG
MGP
CGH
BlackRock's HCM Position: Q1 2026 in Review
BlackRock reduced its HUTCHMED (HCM) stake by 98% in Q1 2026, selling an estimated $569K and leaving 791 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5382.
BlackRock first reported a position in HCM in Q4 2018 and has held it in 30 quarters since. The position peaked at $127M in Q3 2021. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.
- BlackRock held 791 shares of HUTCHMED worth $11.8K as of Q1 2026.
- BlackRock sold 38,888 HUTCHMED shares in Q1 2026, an estimated $569K.
- HUTCHMED made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5382 holding.
- BlackRock first reported a position in HUTCHMED in Q4 2018 and has held it in 30 quarters since.
- BlackRock's HUTCHMED position peaked at $127M in Q3 2021.
- 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.